¿Qué repercusiones tiene la Artritis Reumatoide sobre la vida de los pacientes?

Revista Espanola de Reumatologia

Volumn 27, Issue 6, 2000, Pages 256-259

  Ballina Garcia F J ^a,b   Rodriguez Perez A ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b El Curquedal   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0345418870     PISSN: 03044815     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Fries JF, Ramey DR. Platonic outcomes. J Rheumatol 1993; 20: 415-7.
2. Fries JF. The hierarchy of outcome assessment. J Rheumatol 1993; 20: 546-7.
3. Fries JF. How many quality of life for rheumatoid arthritis patients be enhanced by current and future treatments? Rheumatology 1999; 38 (Supl 2): 35-40.
4. Testa MA, Simonson DC. Assessment of quality of life outcomes. N Engl J Med 1996; 334: 835-40.
5. Katz PP, Yelin EH. Prevalence an correlates of depressive symptoms among persons with rheumatoid arthritis. J Rheumatol 1993; 20: 790-6.
6. Pincus T, Esther R, DeWalt DA, Callahan LF. Social conditions and self-management are more powerful determinants of health than access to care. Ann Intern Med 1998; 129: 406-11.
7. Singh G, Triadafilopoulos G. Epidemiology of NSAID induced gastrointestinal complications. J Rheumatol 1999; 26 (Supl 26): 18-24.
8. Fries JF, Williams CA, Ramey D, Bloch DA. The relative toxicity of disease-modifying antirheumatic drugs. Arthritis Rheum 1993; 36: 297-306.
9. Pincus T, Callahan LF, Sale WG, Brooks AL, Payne LE, Vaughn WK. Severe functional declines, work disability and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 1984; 27: 864-72.
10. Wolfe F, Cathey MA. The assessment and prediction of functional disability in rheumatoid arthritis. J Rheumatol 1991; 18: 1298-306.
11. Leigh JP, Fries JF, Parikh N. Severity of disability and duration of disease in rheumatoid arthritis. J Rheumatol 1992; 19: 1906-11.
12. Suarez-Almanzor ME, Soskolne CL, Saunders D, Russel A. Outcome in rheumatoid arthritis. A 1985 inception cohort study. J Rheumatol 1994; 21: 1438-46.
13. Hakala M, Nieminen P, Koivisto O. More evidence from a community based series of better outcome in rheumatoid arthritis. Data on the effect of multidisciplinary care on the retention of functional ability. J Rheumatol 1994; 21: 1432-7.
14. Van Zeben D, Hazes JMW, Zwinderman AH, Vandenbroucke JP, Breedveld FC. The severity of rheumatoid arthritis: a 6 year follow-up study of younger women with symptoms of recent onset. J Rheumatol 1994; 21: 1620-5.
15. Bergström U, Book C, Lindroth Y, Marsal L, Saxne T, Jacobsson L. Lower disease activity and disability in Swedish patients with rheumatoid arthritis in 1995 compared with 1978. Scand J Rheumatol 1999; 28: 160-5.
16. Pincus T, Callahan LF. How many types of patients meet classification criteria for rheumatoid arthritis. J Rheumatol 1994; 21: 1385-9.
17. Sokka T, Kautiainen H, Möttönen T, Hannonen P. Work disability in rheumatoid arthritis 10 years after the diagnosis. J Rheumatol 1999; 26: 1681-5.
18. Doeglas D, Suurmeijer T, Krol B, Sanderman R, Van Leeuwen M, Rijswijk M. Work disability in early rheumatoid arthritis. Ann Rheum Dis 1995; 54: 455-60.
19. Wolfe F, Hawley DJ. The long-term outcomes of rheumatoid arthritis: work disability: a prospective 18 year study of 823 patients. J Rheumatol 1998; 25: 2108-17.
20. Jäntti J, Aho K, Kaarela K, Kautiainen H. Work disability in an inception cohort of patients with seropositive rheumatoid arthritis: a 20 year study. Rheumatology 1999; 38: 1138-41.
21. Albers JMC, Kuper HH, van Riel PLCM, Prevoo MLL, Van't Hof MA, van Gestel AM et al. Socio-economic consequences of rheumatoid arthritis in the first years of the disease. Rheumatology 1999; 38: 423-30.
22. Yelin E. The costs of rheumatoid arthritis: absolute, incremental and marginal estimates. J Rheumatol 1996; 23 (Supl 44): 47-51.
23. Lajas C, Sánchez C, Bellajdell B, Abasolo L, Fernández-Gutiérrez B, Morado IC et al. Costes anuales de una cohorte de pacientes diagnosticados de artritis reumatoide (AR) en un hospital de Madrid. Rev Esp Reumatol 1999; 26: 157.
24. Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA et al. The mortality of rheumatoid arthritis. Arthritis Rheum 1994; 37: 481-94.
25. Linos A, Worthington JW, O'Fallon WM, Kurland LT. The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality. Am J Epidemiol 1980; 111: 87-98.
26. Wällberg-Jonsson S, Öhman ML, Rantapää Dahiqvist S. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J Rheumatol 1997; 24: 445-51.
27. Silman AJ. Neoplasias malignas en la artritis reumatoide. Rev Esp Reumatol 1989; 16: 119-21.
28. Strand CV, Russell AS. WHO/ILAR on Quality of Life. J Rheumatol 1997; 24: 1630-3.
29. Gilboe I-M, Kvien TK, Husby G. Health status in systemic lupus erythematosus compared to rheumatoid arthritis and healthy controls. J Rheumatol 1999; 26: 1694-1700.
30. Jirout F, Zapico I, Ballina FJ, Hernández R, Rancaǹo I, Álvarez C, Torre JC et al. Estudio transversal de la calidad de vida en pacientes con artritis reumatoide mediante el cuestionario PECVEC. Rev Esp Reumatol 1999; 26: 189.
31. Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care 1989; 27 (Supl): 217-32.
32. Whalley D, McKenna SP, De Jong Z, Van der Heide D. Quality of life in rheumatoid arthritis. Br J Rheumatol 1997; 36: 884-8.